HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inactivation of Rab23 inhibits the invasion and motility of pancreatic duct adenocarcinoma.

Abstract
Pancreatic ductal adenocarcinoma (PDAC) is charac-terized by a poor prognosis and high mortality rate. In this study, we investigated the expression of Rab23 in non-tumor pancreatic tissues and PDACs via immunohistochemistry. Rab23 was found in 39 of 58 (67.2%) and in 11 of 30 (36.7%) of the PDAC and non-tumor pan-creatic tissue samples (P = 0.0073), respectively. There were signifi-cant correlations between Rab23 expression and unfavorable variables, including cancer differentiation level (P = 0.0089), lymph nodal (P = 0.0099), and distant metastases (P = 0.0173). Inactivation with small interfering RNA against Rab23 in the human pancreatic cancer cell line Panc-1 inhibited the migration and invasive potential of the cells. Our data provide new insight into the essential role of Rab23 in PDAC inva-sion and metastasis and suggest that Rab23 expression is a useful indi-cator of metastatic potential; hence, it may be a new therapeutic target for this common malignancy.
AuthorsZ Z Cai, L B Xu, J L Cai, J S Wang, B Zhou, H Hu
JournalGenetics and molecular research : GMR (Genet Mol Res) Vol. 14 Issue 1 Pg. 2707-15 (Mar 30 2015) ISSN: 1676-5680 [Electronic] Brazil
PMID25867419 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RAB23 protein, human
  • rab GTP-Binding Proteins
Topics
  • Blotting, Western
  • Carcinoma, Pancreatic Ductal (genetics, metabolism, pathology)
  • Cell Line
  • Cell Movement (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms (genetics, metabolism, pathology)
  • RNA Interference
  • Reverse Transcriptase Polymerase Chain Reaction
  • rab GTP-Binding Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: